688139 海尔生物
已收盘 09-30 15:00:00
资讯
新帖
简况
海尔生物(688139)9月28日主力资金净卖出1667.83万元
证券之星 · 09-29
海尔生物(688139)9月28日主力资金净卖出1667.83万元
海尔生物:公司未主动申请任何机构的做市业务流程
证券之星 · 09-28
海尔生物:公司未主动申请任何机构的做市业务流程
海尔生物(688139)9月18日股东户数1.46万户,较上期增加1.15%
证券之星 · 09-22
海尔生物(688139)9月18日股东户数1.46万户,较上期增加1.15%
海尔生物:截至2026年9月18日,公司股东总数为14,575户
证券之星 · 09-22
海尔生物:截至2026年9月18日,公司股东总数为14,575户
海尔生物涨8.86%,东海证券六日前给出“买入”评级
证券之星 · 09-21
海尔生物涨8.86%,东海证券六日前给出“买入”评级
每周股票复盘:海尔生物(688139)股东户数增至1.44万户
证券之星 · 09-20
每周股票复盘:海尔生物(688139)股东户数增至1.44万户
海尔生物:截至2026年8月31日公司股东总数为14,353户
证券之星 · 09-14
海尔生物:截至2026年8月31日公司股东总数为14,353户
海尔生物获得发明专利授权:“生物样本冻存装置”
证券之星 · 09-11
海尔生物获得发明专利授权:“生物样本冻存装置”
股市必读:海尔生物(688139)9月10日董秘有最新回复
证券之星 · 09-11
股市必读:海尔生物(688139)9月10日董秘有最新回复
海尔生物:依托"药工共创"模式服务制药产业链
证券之星 · 09-10
海尔生物:依托"药工共创"模式服务制药产业链
海尔生物:公司细胞冻存液采用“预脱水+植冰”仿生冻存技术
证券之星 · 09-08
海尔生物:公司细胞冻存液采用“预脱水+植冰”仿生冻存技术
海尔生物:提供贯穿创新药全生命周期的GXP温控合规解决方案
证券之星 · 09-08
海尔生物:提供贯穿创新药全生命周期的GXP温控合规解决方案
每周股票复盘:海尔生物(688139)已回购697,661股耗资超2082万
证券之星 · 09-06
每周股票复盘:海尔生物(688139)已回购697,661股耗资超2082万
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
证券之星 · 09-03
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,9月1日股价上涨0.9%
证券之星 · 09-01
海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,9月1日股价上涨0.9%
【机构调研记录】红土创新基金调研胜宏科技、海尔生物
证券之星 · 08-31
【机构调研记录】红土创新基金调研胜宏科技、海尔生物
股市必读:海尔生物(688139)8月25日董秘有最新回复
证券之星 · 08-26
股市必读:海尔生物(688139)8月25日董秘有最新回复
海尔生物:可支配资金约25亿元,力争年内取得并购实质性进展
证券之星 · 08-25
海尔生物:可支配资金约25亿元,力争年内取得并购实质性进展
股市必读:海尔生物(688139)8月24日董秘有最新回复
证券之星 · 08-25
股市必读:海尔生物(688139)8月24日董秘有最新回复
海尔生物:截至2026年8月20日,公司股东总数为14,780户
证券之星 · 08-24
海尔生物:截至2026年8月20日,公司股东总数为14,780户
加载更多
公司概况
公司名称:
青岛海尔生物医疗股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-10-25
主营业务:
青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际(Euromonitor)认证,公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。
发行价格:
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":35.85,"timestamp":1790751600000,"preClose":35.19,"halted":0,"volume":4546822,"delay":0,"changeRate":0.0188,"floatShares":316000000,"shares":316000000,"eps":0.807,"marketStatus":"已收盘","change":0.66,"latestTime":"09-30 15:00:00","open":35.19,"high":36.24,"low":35.15,"amount":163000000,"amplitude":0.031,"askPrice":35.85,"askSize":171,"bidPrice":35.82,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.807,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":35.19,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":38.71,"lowLimit":31.67,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.57,"roa":"--","peRate":44.423792,"roe":"3.34%","epsLYR":0.8,"committee":-0.221411,"marketValue":11346000000,"turnoverRate":0.0144,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-08。","afterMarket":{"amount":0,"volume":0,"close":35.85,"buyVolume":0,"sellVolume":0,"time":1790753637746,"indexStatus":"已收盘 09-30 15:30:00","preClose":35.19},"floatMarketCap":11346000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2671266243","title":"海尔生物(688139)9月28日主力资金净卖出1667.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266243?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:26","pubTimestamp":1790641575,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,海尔生物报收于34.8元,上涨0.58%,换手率1.47%,成交量4.64万手,成交额1.62亿元。近5日资金流向一览见下表:海尔生物融资融券信息显示,融资方面,当日融资买入1228.38万元,融资偿还1621.92万元,融资净偿还393.54万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670523287","title":"海尔生物:公司未主动申请任何机构的做市业务流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2670523287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670523287?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:06","pubTimestamp":1790582784,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)09月28日在投资者关系平台上答复投资者关心的问题。投资者提问:上市公司是否可以更换做市商?海尔生物回复:尊敬的投资者,您好!公司未主动申请任何机构的做市业务流程,也未向任何机构提供过相关协助。二级市场股价的短期波动受内外部宏观环境、行业景气度、企业经营业绩等多重因素影响,公司着力提升经营质量,并综合运用并购重组、股权激励、现金分红、投资者关系管理、信息披露、股份回购等多种方式开展市值管理,感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800018492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483561","title":"海尔生物(688139)9月18日股东户数1.46万户,较上期增加1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483561","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669483561?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:32","pubTimestamp":1790069526,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年9月18日公司股东户数为1.46万户,较9月10日增加166.0户,增幅为1.15%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至9月18日,医疗器械行业平均股东户数为2.08万户。从股价来看,2026年9月10日至2026年9月18日,海尔生物区间涨幅为1.16%,在此期间股东户数增加166.0户,增幅为1.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200030297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114433","title":"海尔生物:截至2026年9月18日,公司股东总数为14,575户","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114433","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669114433?lang=zh_cn&edition=full","pubTime":"2026-09-22 15:35","pubTimestamp":1790062526,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至9月18日收盘公司股东人数是多少,谢谢!海尔生物回复:尊敬的投资者您好,截至2026年9月18日,公司股东总数为14,575户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200021566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669599851","title":"海尔生物涨8.86%,东海证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669599851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669599851?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:41","pubTimestamp":1789980062,"startTime":"0","endTime":"0","summary":"今日海尔生物涨8.86%,收盘报34.14元。2026年9月15日,东海证券研究员杜永宏发布了对海尔生物的研报《公司简评报告:国内市场回暖,Q2业绩回升》,该研报对海尔生物给出“买入”评级。公司国内市场回暖向好, 海外市场保持良好增长, 维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为天风证券的郑薇、邹润芳。海尔生物个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668751906","title":"每周股票复盘:海尔生物(688139)股东户数增至1.44万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2668751906","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668751906?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:29","pubTimestamp":1789838952,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘,海尔生物报收于31.36元,较上周的30.82元上涨1.75%。本周,海尔生物9月18日盘中最高价报31.8元。海尔生物当前最新总市值99.25亿元,在医疗器械板块市值排名27/129,在两市A股市值排名1843/5220。户均持股数量由上期的2.21万股下降至2.2万股,户均持股市值为68.09万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655738","title":"海尔生物:截至2026年8月31日公司股东总数为14,353户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667655738?lang=zh_cn&edition=full","pubTime":"2026-09-14 15:36","pubTimestamp":1789371368,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至8月底和9月10日收盘公司股东人数分别是多少,谢谢!海尔生物回复:尊敬的投资者您好,截至2026年8月31日,公司股东总数为14,353户;截至2026年9月10日,公司股东总数为14,409户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400014609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666661513","title":"海尔生物获得发明专利授权:“生物样本冻存装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666661513","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666661513?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:38","pubTimestamp":1789069107,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示海尔生物新获得一项发明专利授权,专利名为“生物样本冻存装置”,专利申请号为CN202311198791.9,授权日为2026年9月1日。今年以来海尔生物新获得专利授权101个,较去年同期增加了60.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100007593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590379","title":"股市必读:海尔生物(688139)9月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590379?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:45","pubTimestamp":1789062318,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,海尔生物报收于31.0元,下跌3.67%,换手率0.98%,成交量3.1万手,成交额9752.82万元。董秘最新回复投资者: 请公司介绍一下此次和药明生物之间的合作涉及哪些方面?上半年,公司在国内进一步巩固与药明生物、金赛药业、片仔癀、齐鲁制药等头部药企的合作关系,业务实现高双位数增长,客户复购率达60%。当日关注点交易信息汇总:9月10日主力资金净流出700.97万元,占总成交额7.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566264","title":"海尔生物:依托\"药工共创\"模式服务制药产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666566264?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:36","pubTimestamp":1789029379,"startTime":"0","endTime":"0","summary":"海尔生物回复:尊敬的投资者您好,公司依托\"药工共创\"模式,深度联动制药企业等生态伙伴,以符合GMP合规及验证体系建设要求的低温工艺为切入点,深入服务制药产业链——涵盖细胞种子库保藏、抗体原液冷冻存储、细胞药物冷冻存储、产品低温转运等核心环节;同时持续拓展离心、培养、冻融等工艺,覆盖更多研发生产环节,并向AI+自动化产线升级方向持续探索并达成合作意向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000029147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01477","BK1574","688139","BK0251","BK1191","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328403","title":"海尔生物:公司细胞冻存液采用“预脱水+植冰”仿生冻存技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665328403?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:34","pubTimestamp":1788852865,"startTime":"0","endTime":"0","summary":"近日,公司“基于‘预脱水+植冰’仿生冻存技术的无 DMSO 细胞冻存液及智能化细胞存储系统”项目从 2141 个参赛项目中脱颖而出,荣获第八届山东省创业大赛一等奖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800019629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665429328","title":"海尔生物:提供贯穿创新药全生命周期的GXP温控合规解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2665429328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665429328?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:34","pubTimestamp":1788852855,"startTime":"0","endTime":"0","summary":"创新药尤其是蛋白类药物和CGT细胞基因治疗的研发与商业化生产高度依赖严苛的低温温控、细胞培养等核心工艺设备及合规体系。③坚持做创新药企项目全生命周期的顾问与伙伴:公司从单纯的产品提供商,升级为早期即介入工艺规划、产线布局与合规方案规划的顾问伙伴,协助国内首个取得GMP证书的商业化细胞药物生产线顺利通过药监GMP审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800019619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD","06978","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665652623","title":"每周股票复盘:海尔生物(688139)已回购697,661股耗资超2082万","url":"https://stock-news.laohu8.com/highlight/detail?id=2665652623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665652623?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:22","pubTimestamp":1788632532,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,海尔生物报收于30.8元,较上周的31.64元下跌2.65%。本周,海尔生物9月1日盘中最高价报31.67元。本周关注点公司公告汇总:海尔生物已累计回购697,661股,支付资金总额超2082万元。公司公告汇总海尔生物关于以集中竞价交易方式回购公司股份的进展公告青岛海尔生物医疗股份有限公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至1亿元,用于减少注册资本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664469118","title":"股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664469118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664469118?lang=zh_cn&edition=full","pubTime":"2026-09-03 03:13","pubTimestamp":1788376390,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,海尔生物报收于31.05元,下跌1.33%,换手率0.85%,成交量2.68万手,成交额8372.18万元。公司公告汇总海尔生物关于以集中竞价交易方式回购公司股份的进展公告青岛海尔生物医疗股份有限公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至1亿元,用于减少注册资本。本次回购符合相关法规及公司方案规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664048857","title":"海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,9月1日股价上涨0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664048857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664048857?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:59","pubTimestamp":1788274750,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,海尔生物报收于31.47元,较前一交易日上涨0.9%,最新总市值为99.6亿元。该股当日开盘31.19元,最高31.67元,最低31.0元,成交额达1.3亿元,换手率为1.31%。近日,海尔生物发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示,公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至1亿元,用于减少注册资本。本次回购符合相关法规及公司方案规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663939028","title":"【机构调研记录】红土创新基金调研胜宏科技、海尔生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2663939028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663939028?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:03","pubTimestamp":1788134636,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月28日披露的机构调研信息,红土创新基金近期对2家上市公司进行了调研,相关名单如下:1)胜宏科技 调研纪要:公司2026年固定资产投资不超过180亿元,主要用于国内扩产。Q2毛利率承压因人员扩张与折旧增加,后续营收增长将带动毛利率回升。旗下最近一年表现最佳的公募基金产品为红土创新新兴产业混合A,最新单位净值为4.41,近一年增长94.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0531971595.HKD","300476","688139","LU1934453819.USD","BK0214","LU1481107354.HKD","02476","LU0164865239.USD","LU0149721374.USD","SGXZ49509284.SGD","BK0197","BK0251","LU0164880469.USD","LU0469268626.HKD","BK1170","SGXZ81163826.USD","LU2488822045.USD","LU1808992512.USD","LU0871576103.HKD","LU0039217434.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662768620","title":"股市必读:海尔生物(688139)8月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662768620?lang=zh_cn&edition=full","pubTime":"2026-08-26 07:06","pubTimestamp":1787699181,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,海尔生物报收于30.01元,上涨3.48%,换手率1.34%,成交量4.23万手,成交额1.26亿元。截至2026年上半年,公司并购子公司的资本回报率整体达双位数,并购业务收入复合增长率达30%,对整体收入贡献已超30%。后续若有实质进展,公司将依法依规履行信披义务,请您留意公司相关公告。当日关注点交易信息汇总:8月25日主力资金净流入239.63万元,占总成交额1.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600012155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782190","title":"海尔生物:可支配资金约25亿元,力争年内取得并购实质性进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662782190?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:22","pubTimestamp":1787646162,"startTime":"0","endTime":"0","summary":"有投资者在互动平台向海尔生物提问,公司目前账面现金储备是否支持规模较大的外延式并购,以及资本开支方面的优先级如何。海尔生物回复称,截至2026年上半年,公司含货币资金、其他非流动资产在内的可支配资金合计约25亿元,占总资产比重超过40%,资产负债率长期维持在20%左右。目前主要围绕两条主线推进并购布局:一是生物制造核心装备和试剂耗材,二是通过技术外延支持新场景拓展,并力争年内取得实质性进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082500032931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662145205","title":"股市必读:海尔生物(688139)8月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662145205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662145205?lang=zh_cn&edition=full","pubTime":"2026-08-25 03:39","pubTimestamp":1787600372,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,海尔生物报收于29.0元,下跌1.83%,换手率1.39%,成交量4.4万手,成交额1.28亿元。董秘最新回复投资者: 您好!请问截至8月20日收盘公司股东人数是多少,谢谢!董秘: 尊敬的投资者您好,截至2026年8月20日,公司股东总数为14,780户。当日关注点交易信息汇总:8月24日主力资金净流入69.1万元,占总成交额0.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500008011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222740","title":"海尔生物:截至2026年8月20日,公司股东总数为14,780户","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661222740?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:54","pubTimestamp":1787565258,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至8月20日收盘公司股东人数是多少,谢谢!海尔生物回复:尊敬的投资者您好,截至2026年8月20日,公司股东总数为14,780户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400025146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791094983895,"stockEarnings":[{"period":"1week","weight":0.0222},{"period":"1month","weight":0.1494},{"period":"3month","weight":0.3362},{"period":"6month","weight":0.1642},{"period":"1year","weight":0.1117},{"period":"ytd","weight":0.1418}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14575人(较上一季度增加1.15%)","perCapita":"21714股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际(Euromonitor)认证,公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}